» Articles » PMID: 30467188

Suppression Benefits β-thalassemic Erythropoiesis

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2018 Nov 24
PMID 30467188
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Transferrin Receptors in Erythropoiesis.

Richard C, Verdier F Int J Mol Sci. 2020; 21(24).

PMID: 33352721 PMC: 7766611. DOI: 10.3390/ijms21249713.

References
1.
Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C . Hepcidin is decreased in TFR2 hemochromatosis. Blood. 2004; 105(4):1803-6. DOI: 10.1182/blood-2004-08-3042. View

2.
Gardenghi S, Ramos P, Marongiu M, Melchiori L, Breda L, Guy E . Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest. 2010; 120(12):4466-77. PMC: 2993583. DOI: 10.1172/JCI41717. View

3.
Artuso I, Lidonnici M, Altamura S, Mandelli G, Pettinato M, Muckenthaler M . Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model. Blood. 2018; 132(21):2286-2297. PMC: 6302281. DOI: 10.1182/blood-2018-05-852277. View

4.
Wallace D, Secondes E, Rishi G, Ostini L, McDonald C, Lane S . A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction. Br J Haematol. 2014; 168(6):891-901. DOI: 10.1111/bjh.13225. View

5.
Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M . The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000; 25(1):14-5. DOI: 10.1038/75534. View